AppExchange launch. Security Review passed first time.
Designed, built, and published a native AppExchange product for clinical trial management — passing Salesforce Security Review on first submission.
The challenge
What needed solving.
LifeSciences+ had deep domain expertise in clinical trial management but no software product. Their consultants manually configured Salesforce for each new pharma client — a process that took 12 weeks per engagement. The founders wanted to productise their methodology as a native Salesforce app, but had no experience with AppExchange development, Managed Packages, or the Security Review process.
The solution
What we built.
We designed and built a fully native Salesforce Managed Package for clinical trial management — covering site activation, patient enrolment, adverse event tracking, and regulatory reporting. The app passed Salesforce Security Review on the first submission (an uncommon achievement) and launched with 200+ enterprise customers pre-committed from LifeSciences+'s existing client base.
Product architecture
Designed the managed package schema, namespace strategy, and feature toggle system to support configurable deployment across client orgs.
Core feature build
Built 6 LWC modules covering trial site management, patient enrolment tracking, protocol deviation logging, and regulatory submission templates.
Security Review preparation
Conducted a full security audit against Salesforce's checkmarx rules, remediated all findings, and prepared the Security Review submission package.
AppExchange listing & launch
Produced the listing content, demo org, and installation documentation. Coordinated the go-live with LifeSciences+'s sales team for a simultaneous customer announcement.
The results
Measurable outcomes.
"CloudAlgo didn't just build the app — they taught us how to think like a software product company. The Security Review pass on first submission saved us months.
Tech stack
Work with us
Ready to get results like these?
Tell us about your project — we'll scope it and respond within one business day.